相似文献
1
Role of Ubiquitin Ligases and Conjugases in Targeted Cancer Therapy.
Cancers (Basel). 2023 Jul 1;15(13):3460. doi: 10.3390/cancers15133460.
2
Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes.
Int J Mol Sci. 2022 Oct 15;23(20):12330. doi: 10.3390/ijms232012330.
3
The pineal gland: A model for adrenergic modulation of ubiquitin ligases.
PLoS One. 2017 Feb 17;12(2):e0172441. doi: 10.1371/journal.pone.0172441. eCollection 2017.
4
Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer.
Cancers (Basel). 2021 May 28;13(11):2659. doi: 10.3390/cancers13112659.
5
Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.
Cell Mol Neurobiol. 2023 May;43(4):1425-1452. doi: 10.1007/s10571-022-01261-0. Epub 2022 Jul 27.
6
Role of E3 ubiquitin ligases in lung cancer.
World J Clin Oncol. 2013 Aug 10;4(3):58-69. doi: 10.5306/wjco.v4.i3.58.
7
Seek and destroy: the ubiquitin----proteasome system in cardiac disease.
Curr Hypertens Rep. 2009 Dec;11(6):396-405. doi: 10.1007/s11906-009-0069-7.
8
Ubiquitin proteasome system in immune regulation and therapeutics.
Curr Opin Pharmacol. 2022 Dec;67:102310. doi: 10.1016/j.coph.2022.102310. Epub 2022 Oct 23.
9
Targeting E3 ubiquitin ligases for cancer therapy.
Cancer Biol Ther. 2003 Nov-Dec;2(6):623-9.
10
Analysis of Proteasome-Associated Ubiquitin Ligase Activity.
Methods Mol Biol. 2023;2581:57-67. doi: 10.1007/978-1-0716-2784-6_5.
本文引用的文献
1
AtomNet-Aided OTUD7B Inhibitor Discovery and Validation.
Cancers (Basel). 2023 Jan 14;15(2):517. doi: 10.3390/cancers15020517.
2
PROTAC therapy as a new targeted therapy for lung cancer.
Mol Ther. 2023 Mar 1;31(3):647-656. doi: 10.1016/j.ymthe.2022.11.011. Epub 2022 Nov 22.
3
The E3 Ligases in Cervical Cancer and Endometrial Cancer.
Cancers (Basel). 2022 Oct 30;14(21):5354. doi: 10.3390/cancers14215354.
4
Pan-Cancer Bioinformatics Analysis of Gene UBE2C.
Front Genet. 2022 Apr 27;13:893358. doi: 10.3389/fgene.2022.893358. eCollection 2022.
5
The Emerging Role of E3 Ubiquitin Ligase SMURF2 in the Regulation of Transcriptional Co-Repressor KAP1 in Untransformed and Cancer Cells and Tissues.
Cancers (Basel). 2022 Mar 22;14(7):1607. doi: 10.3390/cancers14071607.
6
Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma.
Cell Death Discov. 2022 Mar 24;8(1):130. doi: 10.1038/s41420-022-00935-4.
7
Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors.
Sci Rep. 2022 Mar 18;12(1):4696. doi: 10.1038/s41598-022-08210-3.
8
Clinical considerations for the design of PROTACs in cancer.
Mol Cancer. 2022 Mar 7;21(1):67. doi: 10.1186/s12943-022-01535-7.
9
Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening.
Cancers (Basel). 2022 Feb 17;14(4):1009. doi: 10.3390/cancers14041009.
10
E3 ligase RNF167 and deubiquitinase STAMBPL1 modulate mTOR and cancer progression.
Mol Cell. 2022 Feb 17;82(4):770-784.e9. doi: 10.1016/j.molcel.2022.01.002. Epub 2022 Feb 2.
Zotero 插件